Gunnar Wagenius

Publications
Public outreach and news

Articles

Article: CANCER CAUSES & CONTROL. 2021;32(6):597-607
Antibiotic use prior to a lung cancer diagnosis: a population-based study
Lofling L; Bahmanyar S; Kieler H; Lambe M; Wagenius G
Article: CANCER TREATMENT AND RESEARCH COMMUNICATIONS. 2020;24:100187
Definitive chemoradiotherapy plus cetuximab for cancer in the oesophagus or gastro-oesophageal junction.
von Döbeln GA; Wagenius G; Holtved E; Jacobsen A-B; Nilsson M; Yu J; Baeksgaard L
Article: LUNG CANCER. 2020;139:111-117
Educational level, management and outcomes in small-cell lung cancer (SCLC): A population-based cohort study
Tendler S; Holmqvist M; Wagenius G; Lewensohn R; Lambe M; De Petris L
Article: ACTA ONCOLOGICA. 2019;58(11):1618-1627
Clinical characteristics and survival in non-small cell lung cancer patients by smoking history: a population-based cohort study
Lofling L; Karimi A; Sandin F; Bahmanyar S; Kieler H; Lambe M; Lamberg K; Wagenius G
Article: LUNG CANCER. 2019;131:40-46
Educational level and management and outcomes in non-small cell lung cancer. A nationwide population-based study
Willen L; Berglund A; Bergstrom S; Bergqvist M; Ojdahl-Boden A; Wagenius G; Lambe M
Article: PLOS ONE. 2019;14(6):e0219206
Sex and survival in non-small cell lung cancer: A nationwide cohort study
Radkiewicz C; Dickman PW; Johansson ALV; Wagenius G; Edgren G; Lambe M
Article: ACTA ONCOLOGICA. 2015;54(4):447-453
Multidisciplinary team conferences promote treatment according to guidelines in rectal cancer
Brannstrom F; Bjerregaard JK; Winbladh A; Nilbert M; Revhaug A; Wagenius G; Morner M
Article: EUROPEAN JOURNAL OF CANCER. 2013;49(12):2705-2716
Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: A nationwide population-based study in Sweden
Eriksson H; Lyth J; Mansson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
Article: ACTA ONCOLOGICA. 2013;52(5):978-986
Rapid expansion of T cells: Effects of culture and cryopreservation and importance of short-term cell recovery.
Sadeghi A; Ullenhag G; Wagenius G; Tötterman TH; Eriksson F
Article: BRITISH JOURNAL OF DERMATOLOGY. 2013;168(4):779-786
Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register
Lyth J; Hansson J; Ingvar C; Mansson-Brahme E; Naredi P; Stierner U; Wagenius G; Lindholm C
Article: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2012;61(5):725-732
Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy.
Ullenhag GJ; Sadeghi AM; Carlsson B; Ahlström H; Mosavi F; Wagenius G; Tötterman TH
Article: LUNG CANCER. 2011;71(2):166-172
Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: Satellite-A phase II study from the Swedish Lung Cancer Study Group
Hallqvist A; Wagenius G; Rylander H; Brodin O; Holmberg E; Loden B; Ewers S-B; Bergstrom S; Wichardt-Johansson G; Nilsson K; Ekberg L; Sederholm C; Nyman J
Article: THORAX. 2010;65(4):327-333
Social inequalities in non-small cell lung cancer management and survival: a population-based study in central Sweden
Berglund A; Holmberg L; Tishelman C; Wagenius G; Eaker S; Lambe M
Article: LUNG CANCER. 2009;65(1):62-67
How to improve loco-regional control in stages IIIa-b NSCLC? Results of a three-armed randomized trial from the Swedish Lung Cancer Study Group
Nyman J; Friesland S; Hallqvist A; Seke M; Bergstrom S; Thaning L; Loden B; Sederholm C; Wagenius G
Article: LUNG CANCER. 2009;63(1):16-22
Regional differences in treatment and outcome in non-small cell lung cancer: A population-based study (Sweden)
Myrdal G; Lamberg K; Lambe M; Stahle E; Wagenius G; Holmberg L
Article: MELANOMA RESEARCH. 2008;18(6):412-419
Serological and immunohistochemical analysis of S100 and new derivatives as markers for prognosis in patients with malignant melanoma
Bolander A; Agnarsdottir M; Wagenius G; Stromberg S; Ponten F; Ekman S; Brattstrom D; Larsson A; Einarsson R; Ullenhag G; Hesselius P; Bergqvist M
Article: JOURNAL OF IMMUNOTHERAPY. 2008;31(7):633-643
Effector T cell analysis of melanoma tumor-infiltrating lymphocyte cultures using HLA-ABC semimatched melanoma cell lines.
Carlsson B; Sadeghi A; Bengtsson M; Wagenius G; Tötterman TH
Article: MEDICAL ONCOLOGY. 2007;24(4):407-412
Phase II studies on docetaxel alone every third week, or weekly in combination with gemcitabine in patients with primary locally advanced, metastatic, or recurrent esophageal cancer
Albertsson M; Johansson B; Friesland S; Kadar L; Letocha H; Frykholm G; Wagenius G
Article: ANTICANCER RESEARCH. 2007;27(5A):3211-3217
The role of circulating angiogenic factors in patients operated on for localized malignant melanoma.
Bolander A; Wagenius G; Larsson A; Brattström D; Ullenhag G; Hesselius P; Ekman S; Bergqvist M
Article: JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2006;12(4):183-191
Physical exercise for cytotoxic drug-induced fatigue.
Hartvig P; Aulin J; Wallenberg S; Wagenius G
Article: JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2006;12(3):155-164
Fatigue in cancer patients treated with cytotoxic drugs.
Hartvig P; Aulin J; Hugerth M; Wallenberg S; Wagenius G
Article: DISEASES OF THE ESOPHAGUS. 2006;19(4):224-231
HER-2 overexpression (3+) in patients with squamous cell esophageal carcinoma correlates with poorer survival.
Dreilich M; Wanders A; Brattström D; Bergström S; Hesselius P; Wagenius G; Bergqvist M
Article: MELANOMA RESEARCH. 2006;16(4):357-363
Alternating chemo-immunotherapy with temozolomide and low-dose interleukin-2 in patients with metastatic melanoma
Masucci GV; Mansson-Brahme E; Ragnarsson-Olding B; Nilsson B; Wagenius G; Hansson J
Article: ANTI-CANCER DRUGS. 2006;17(5):503-509
Telomerase activity is not a key determinant of sensitivity to standard cytotoxic drugs in human esophageal carcinoma cell lines.
Dreilich M; Lindkvist A; Dhar S; Paulsson-Karlsson Y; Brattström D; Nygren P; Rickardson L; Wagenius G; Bergqvist M
Article: BMC CANCER. 2006;6:94
High-risk human papilloma virus (HPV) and survival in patients with esophageal carcinoma: a pilot study.
Dreilich M; Bergqvist M; Moberg M; Brattström D; Gustavsson I; Bergström S; Wanders A; Hesselius P; Wagenius G; Gyllensten U
Article: DISEASES OF THE ESOPHAGUS. 2006;19(1):20-23
Genes associated with telomerase activity levels in esophageal carcinoma cell lines.
Bergqvist M; Brattström D; Brodin D; Lindkvist A; Dahlman-Wright K; Dreilich M; Wagenius G; Paulsson-Karlsson Y
Article: NEOPLASMA. 2006;53(4):285-290
Role of circulating cytokeratin fragments and angiogenic factors in NSCLC patients stage IIIa-IIIb receiving curatively intended treatment.
Eriksson P; Brattström D; Hesselius P; Larsson A; Bergström S; Ekman S; Goike H; Wagenius G; Brodin O; Bergqvist M
Article: DISEASES OF THE ESOPHAGUS. 2005;18(5):298-303
Newly developed assay measuring cytokeratins 8, 18 and 19 in serum is correlated to survival and tumor volume in patients with esophageal carcinoma
Brattström D; Wagenius G; Sandström P; Dreilich M; Bergström S; Goike H; Hesselius P; Bergqvist M
Article: MEDICAL ONCOLOGY. 2005;22(1):29-38
The role of cystatin C and the angiogenic cytokines VEGF and bFGF in patients with esophageal carcinoma.
Dreilich M; Wagenius G; Bergström S; Brattström D; Larsson A; Hesselius P; Bergqvist M
Article: CANCER. 2004;101(9):2067-2078
Invasive cutaneous malignant melanoma in Sweden, 1990-1999 -: A prospective, population-based study of survival and prognostic factors
Lindholm C; Andersson R; Dufmats M; Hansson J; Ingvar C; Möller T; Sjödin H; Stierner U
Article: BMC CANCER. 2004;4:66
The role of circulating anti-p53 antibodies in patients with advanced non-small cell lung cancer and their correlation to clinical parameters and survival.
Bergqvist M; Brattström D; Larsson A; Hesselius P; Brodin O; Wagenius G
Article: IN VIVO. 2004;18(5):615-620
The presence of anti-p53 antibodies in sera from patients with oesophageal carcinoma: correlation to treatment, tumour volume and survival.
Bergström S; Dreilich M; Wagenius G; Brattström D; Larsson A; Hesselius P; Bergqvist M
Article: MEDICAL SCIENCE MONITOR. 2004;10(9):BR331-BR338
Endothelial markers and circulating angiogenic factors and p53 may be potential markers for recurrence in surgically resected non-small cell lung cancer patients.
Brattström D; Bergqvist M; Wester K; Hesselius P; Ren Z-P; Scheibenpflug L; Wagenius G; Brodin O
Article: LARYNGOSCOPE. 2004;114(9):1660-1667
High-dose cisplatin with amifostine: Ototoxicity and pharmacokinetics
Ekborn A; Hansson J; Ehrsson H; Eksborg S; Wallin I; Wagenius G; Laurell G
Article: ANTICANCER RESEARCH. 2004;24(3b):1915-1920
A retrospective study focusing on clinical predictive factors in 126 patients with oesophageal carcinoma.
Dreilich M; Bergström S; Wagenius G; Brattström D; Bergqvist M
Article: ACTA ONCOLOGICA. 2004;43(1):80-86
HER-2, EGFR, COX-2 expression status correlated to microvessel density and survival in resected non-small cell lung cancer.
Brattström D; Wester K; Bergqvist M; Hesselius P; Malmström P-U; Nordgren H; Wagenius G; Brodin O
Article: MEDICAL ONCOLOGY. 2004;21(3):241-250
Serum semicarbazide-sensitive amine oxidase (SSAO) activity correlates with VEGF in non-small-cell lung cancer patients.
Garpenstrand H; Bergqvist M; Brattström D; Larsson A; Oreland L; Hesselius P; Wagenius G
Article: LUNG CANCER. 2004;43(1):55-62
Serum VEGF and bFGF adds prognostic information in patients with normal platelet counts when sampled before, during and after treatment for locally advanced non-small cell lung cancer.
Brattström D; Bergqvist M; Hesselius P; Larsson A; Wagenius G; Brodin O
Article: NEOPLASIA. 2003;5(4):283-287
The presence of anti-p53 antibodies in sera prior to thoracic surgery in non small cell lung cancer patients: its implications on tumor volume, nodal involvement, and survival.
Bergqvist M; Brattström D; Lamberg K; Hesselius P; Wernlund J; Larsson A; Wagenius G
Article: ANTICANCER RESEARCH. 2003;23(2B):1207-1212
p53 status and its in vitro relationship to radiosensitivity and chemosensitivity in lung cancer.
Bergqvist M; Brattström D; Gullbo J; Hesselius P; Brodin O; Wagenius G
Article: LUNG CANCER. 2002;37(1):57-63
Elevated preoperative serum levels of angiogenic cytokines correlate to larger primary tumours and poorer survival in non-small cell lung cancer patients.
Brattström D; Bergqvist M; Hesselius P; Larsson A; Lamberg K; Wernlund J; Brodin O; Wagenius G
Article: ANTICANCER RESEARCH. 2001;21(6A):4141-4145
Serum p53 autoantibodies as prognostic marker in patients with oesophageal carcinoma.
Bergqvist AS; Bergqvist M; Brattstrom D; Hesselius P; Larsson A; Brodin O; Wagenius G
Article: ANTICANCER RESEARCH. 2001;21(6A):3925-3928
Radiation responsiveness of human lung cancer cell lines measured with a short term semiautomatic assay.
Xing T; Brattstrom D; Bergqvist M; Isaksson U; Wagenius G; Brodin O
Article: ANTICANCER RESEARCH. 2001;21(6A):3853-3856
The frequency of micronuclei in lung cancer cell lines and their correlation to intrinsic radiation sensitivity.
Bergqvist AS; Brattström D; Bergqvist M; Brodin O; Wagenius G; Zetterberg LA
Article: CANCER CAUSES & CONTROL. 2001;12(6):539-549
Trends in lung cancer incidence in Sweden with special reference to period and birth cohorts
Myrdal G; Lambe M; Bergström R; Ekbom A; Wagenius G; Ståhle E
Article: ACTA ONCOLOGICA. 2001;40(5):566-573
A Swedish study of chemoradiation in squamous cell carcinoma of the esophagus
Stockeld D; Tennvall J; Wagenius G; Albertsson M; Backman L; Brodin O; Cwikiel M; Granström L; Gustafsson G; Gustavsson S; Hambraeus G; Lewensohn R; Sjöstedt S; Strander H; Åberg B; Fagerberg J
Article: ANTICANCER RESEARCH. 2000;20(3B):2087-2090
Different fraction schedules and combinations with chemotherapy in radiation treatment of non-small cell lung cancer.
Brattström D; Bergqvist M; Hesselius P; Wagenius G; Brodin O
Article: LUNG CANCER. 1999;26(2):85-94
Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer.
ten Bokkel Huinink WW; Bergman B; Chemaissani A; Dornoff W; Drings P; Kellokumpu-Lehtinen PL; Liippo K; Mattson K; von Pawel J; Ricci S; Sederholm C; Stahel RA; Wagenius G; Walree NV; Manegold C
Article: ANTICANCER RESEARCH. 1999;19(3A):1833-1836
Cytokeratin 8 and 18 fragments measured in serum and their relation to survival in patients with non-small cell lung cancer.
Bergqvist M; Brattström D; Hesselius P; Wiklund B; Silen A; Wagenius G; Brodin O
Article: ACTA ONCOLOGICA. 1999;38(2):159-164
Aspects on reducing gastrointestinal adverse effects associated with radiotherapy.
Henriksson R; Bergström P; Franzén L; Lewin F; Wagenius G
Article: MEDICAL ONCOLOGY. 1998;15(4):255-261
Complete sequence of p53 gene in 20 patients with lung cancer: comparison with chemosensitivity and immunohistochemistry.
Brattström D; Bergqvist M; Lamberg K; Kraaz W; Scheibenflug L; Gustafsson G; Inganäs M; Wagenius G; Brodin O
Article: ANTICANCER RESEARCH. 1998;18(3B):1999-2002
P53 auto-antibodies in non-small cell lung cancer patients can predict increased life expectancy after radiotherapy.
Bergqvist M; Brattström D; Larsson A; Holmertz J; Hesselius P; Rosenberg L; Wagenius G; Brodin O
Article: LUNG CANCER. 1998;20(1):57-63
Irradiation of brain metastases from lung cancer: a retrospective study.
Bergqvist M; Brattström D; Bennmarker H; Wagenius G; Riska H; Brodin O
Article: ANTICANCER RESEARCH. 1998;18(2A):1123-1127
Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients.
Brattström D; Bergqvist M; Larsson A; Holmertz J; Hesselius P; Rosenberg L; Brodin O; Wagenius G
Article: ANNALS OF ONCOLOGY. 1997;8(6):525-529
Single-agent gemcitabine versus cisplatin-etoposide: early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer.
Manegold C; Bergman B; Chemaissani A; Dornoff W; Drings P; Kellokumpu-Lehtinen P; Liippo K; Mattson K; van Pawel J; Ricci S; Sederholm C; Stahel RA; Wagenius G; van Walree N; ten Bokkel-Huinink W
Show more

All other publications

Letter: ACTA ONCOLOGICA. 2020;59(1):28-32
Analysis of human papillomaviruses and human polyomaviruses in lung cancer from Swedish never-smokers
Ramqvist T; Ortiz-Villalon C; Branden E; Koyi H; de Petris L; Wagenius G; Brodin O; Reutersward C; Dalianis T; Jonsson M; Staaf J; Lewensohn R; Planck M
Letter: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2012;61(5):749
Response to the letter to the editors from Inge Marie Svane on our manuscript "Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy"
Wagenius G; Ullenhag GJ; Totterman TH
Published conference paper: SEMINARS IN ONCOLOGY. 1997;24(3):s8-13-s8-17-817
A randomized study of gemcitabine monotherapy versus Etoposide/Cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer
Manegold C; Drings P; vonPawel J; Ricci S; Dornoff W; vanWalree N; Huinink WT; Chemaissani A; Stahel P; Bergman B; Wagenius G; Sederholm C; Mattson K; Liippo K; KellokumpuLehtinen P

Articles

All other publications

News from KI

Events from KI